Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Metastasectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 4 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Castration-resistant Prostate Cancer 2 Urologic Neoplasms 1 Sarcoma 1 Osteosarcoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphatic Metastasis 1 Ependymoma 1 Colonic Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Breast Neoplasms 1 Abdominal Neoplasms 1

Interventions

pembrolizumab 129 Gemcitabine 115 Capecitabine 107 Fluorouracil 99 Paclitaxel 98 Bevacizumab 91 Oxaliplatin 89 Nivolumab 86 Leucovorin 81 Docetaxel 80 Radiosurgery 79 Irinotecan 72 Carboplatin 70 Cisplatin 69 Cetuximab 61 Cyclophosphamide 60 Magnetic Resonance Spectroscopy 59 Specimen Handling 54 Biopsy 53 Radiotherapy 48 Trastuzumab 47 Ipilimumab 44 Drug Therapy 43 Pemetrexed 38 Everolimus 38 Albumin-Bound Paclitaxel 37 130-nm albumin-bound paclitaxel 37 Fulvestrant 36 Doxorubicin 34 aldesleukin 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05352178 2024-07-03

SPARKLE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡